Clinical Trial Update: Changing to Nonprotease Inhibitor Treatment to Improve Side Effects [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining switching to nonprotease inhibitor therapy to improve side effects in people with HIV infections and lipodystrophy; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Lipodystrophy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Lipodystrophy | Phase 2 | Status: COMPLETED